TY  - GEN
AU  - Coles,Alasdair J
AU  - Compston,D Alastair S
AU  - Selmaj,Krzysztof W
AU  - Lake,Stephen L
AU  - Moran,Susan
AU  - Margolin,David H
AU  - Norris,Kim
AU  - Tandon,P K
TI  - Alemtuzumab vs. interferon beta-1a in early multiple sclerosis
SN  - 1533-4406
PY  - 2008///1030
KW  - Adjuvants, Immunologic
KW  - adverse effects
KW  - Adolescent
KW  - Adult
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neoplasm
KW  - Autoimmune Diseases
KW  - chemically induced
KW  - Female
KW  - Humans
KW  - Infections
KW  - Interferon beta-1a
KW  - Interferon-beta
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Middle Aged
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - drug therapy
KW  - Purpura, Thrombocytopenic
KW  - Thyroid Diseases
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1056/NEJMoa0802670
ER  -